Search

everythinglearnresearchcommunity

for

Search:↓

Future hormone therapy trials should match the diverse needs and priorities of the gender-diverse community.

Transgender patients face more barriers to oral healthcare, leading to poorer oral health and quality of life.

PTHrP and its receptor can control blood vessel growth and hair development in mouse skin.

Testosterone treatment in transgender teens can worsen acne, requiring careful treatment due to mental health and medication side effects.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Laser hair removal doesn't affect thyroid hormones.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Research on transgender men needs clearer theories to improve understanding and decision-making.

Facial hair is crucial for gender affirmation, but many face financial barriers to achieving desired results.

Finasteride effectively treats hair loss in transgender men with few side effects.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Provide individualized, supportive care for transgender and non-binary adolescents to improve their well-being.

AGA treatments like minoxidil and LLLLT are safe and effective for gender minority patients.

Young transgender, gender diverse, and nonbinary people on spironolactone have a low risk of high potassium, so frequent monitoring may not be needed.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Transgender females can reach their target estrogen levels using estradiol patches, especially if oral treatments fail or if they're at risk for blood clots. Often, the highest dose patch is needed.

Progranulin overexpression leads to shorter, thinner hair and increased cell death in mouse hair follicles.

Scientists restored fertility in male mice lacking a key fertility gene by using a modified gene.

Minoxidil, finasteride, and low-level laser light therapy are effective FDA-approved treatments for hair loss.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Both injectable contraceptives lower testosterone and SHBG levels, with NET-EN having a greater effect than DMPA-IM.

Many children and teens referred to gender services receive hormone treatments, but more research is needed on their long-term care and outcomes.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Inclusive and culturally competent healthcare is crucial for transgender and non-binary individuals.

The document recommends a multidisciplinary approach and experience sharing to advance facial feminization surgery as a medical field.

Dermatologists are important in helping transgender people with skin issues and physical changes during their transition.

Fat cells are important for healthy skin, hair growth, and healing, and changes in these cells can affect skin conditions and aging.

Mutations in the hairless gene in mice affect its expression and lead to a range of developmental issues in multiple tissues.